DEVELOPING MONOCLONAL ANTIBODIES: CHALLENGES AND SOLUTIONS
Monoclonal antibodies (mAbs) used for immunotherapy stimulate the immune system to mount a response to target antigens. These powerful therapeutics are being used to target various conditions including cancer and autoimmune diseases, and those with superior target reactivity and optimal function are the best candidates for development. Despite technological and methodological advancements, developing new monoclonal antibodies can be challenging.
Download this infographic from Sartorius to explore some common challenges to mAb development and their potential solutions!
The Scientist c/o LabX Media Group 1000 N West Street, Suite 1200,Wilmington, Delaware, United States,19801 Toll Free: 888.788.0328 | Phone: 705.528.6888 Email: firstname.lastname@example.org